Gemini Therapeutics Inc (GMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMTX | CSBR | CARM | ||
| Company | Gemini Therapeutics Inc | Champions Oncolog | Carisma Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.6000 | 4.67 | 1.4200 | ||
| High | 14.1000 | 4.82 | 1.4200 | ||
| Low | 13.5000 | 4.67 | 1.3500 | ||
| Last | 13.5000 | 4.70 | 1.4100 | ||
| Change | unch | -0.03 | +0.0400 | ||
| % Change | unch | -0.63% | +2.92% | ||
| Volume | 6,380 | 2,745 | 219,948 | ||
| 20-Day Average Volume | 176,225 | 6,112 | 144,823 | ||
| Previous Close | 13.5000 | 4.73 | 1.3700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5780 | 4.89 | 1.5733 | ||
| 20-Day Raw Stochastic | 30.91% | 41.37% | 7.96% | ||
| 20-Day Relative Strength | 33.17% | 43.87% | 32.19% | ||
| Weighted Alpha | -39.50 | -14.75 | -65.19 | ||
| Today's Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 96% Buy | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.34% since 12/21/22 | -1.24% since 05/10/24 | -6.08% since 05/10/24 | ||
| Low | 1.1800 on 12/28/22 | 4.51 on 05/15/24 | 1.3450 on 05/15/24 | ||
| High | 1.7100 on 12/27/22 | 4.87 on 05/16/24 | 1.5300 on 05/14/24 | ||
| 1-Month | |||||
| %Chg | -21.97% since 11/29/22 | -5.17% since 04/17/24 | -17.75% since 04/17/24 | ||
| Low | 1.1800 on 12/28/22 | 4.51 on 05/15/24 | 1.3450 on 05/15/24 | ||
| High | 1.7300 on 12/05/22 | 5.14 on 04/25/24 | 1.9100 on 04/23/24 | ||
| 3-Month | |||||
| %Chg | -11.18% since 09/29/22 | -17.47% since 02/16/24 | -39.57% since 02/16/24 | ||
| Low | 1.1800 on 12/28/22 | 4.51 on 05/15/24 | 1.3450 on 05/15/24 | ||
| High | 2.1000 on 10/26/22 | 6.25 on 03/07/24 | 2.7700 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | -21.97% since 06/29/22 | -12.80% since 11/17/23 | -44.18% since 11/17/23 | ||
| Low | 1.1800 on 12/28/22 | 4.51 on 05/15/24 | 1.3450 on 05/15/24 | ||
| High | 2.1200 on 08/11/22 | 7.13 on 01/17/24 | 3.1600 on 12/26/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,493 | 64,300 | 56,914 | ||
| Shares Outstanding, K | 43,328 | 13,594 | 41,543 | ||
| Annual Sales | 0 | 53,870,000 | 14,920,000 | ||
| Annual Net Income | -71,870,000 | -5,340,000 | -86,880,000 | ||
| Last Quarter Sales | 0 | 12,020,000 | 3,400,000 | ||
| Last Quarter Net Income | -3,280,000 | -2,530,000 | -18,980,000 | ||
| 60-Month Beta | -0.12 | 0.40 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 11/10/22 | -0.19 on 03/12/24 | -0.46 on 05/09/24 | ||
| Latest Earnings Date | 11/21/22 | 03/20/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||